CL 426 (Entecavir 0.5 mg)
Pill with imprint CL 426 is White, Three-sided and has been identified as Entecavir 0.5 mg. It is supplied by Cipla USA Inc..
Entecavir is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Entecavir 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CL 426
Entecavir
- Imprint
- CL 426
- Strength
- 0.5 mg
- Color
- White
- Size
- 9.00 mm
- Shape
- Three-sided
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- National Drug Code (NDC)
- 69097-0426
- Inactive Ingredients
-
lactose monohydrate, microcrystalline cellulose, povidone, magnesium stearate, titanium dioxide, hypromellose 2910 (15 mPa.s), polyethylene glycol 6000
Note: Inactive ingredients may vary.
More about entecavir
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 2 Reviews
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Consumer resources
Other brands: Baraclude
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
